Directory
>
Alison Pilgrim
Alison Pilgrim
Partner | Humacyte
California, United States
Alison Pilgrim
Summary
Alison Pilgrim is a seasoned professional in the pharmaceutical and biopharmaceutical industry with over three decades of experience. Currently a Partner at Competitive Drug Development SARL, she has held multiple leadership roles including Chief Medical Officer at Humacyte and Colucid Pharmaceuticals. Alison's expertise spans clinical development, drug discovery, and strategic planning, making her a valuable asset in the management of clinical trials and drug development processes. Her academic background includes a DPhil in Medicine and Neurobiology from the University of Oxford, which laid the foundation for her successful career. Known for her strategic insights and innovative approach, she has contributed to the advancement of medical devices and oncology research. Alison's extensive experience in both corporate and consulting environments enhances her adaptability and effectiveness in the fast-paced pharmaceutical landscape.
Alison Pilgrim
Work Experience
Partner at
Competitive Drug Development
April 2013 - Present
Chief Medical Officer at
Humacyte
January 2011 - Present
Partner at
Competitive Drug Development
January 2005 - Present
Chief Medical Officer at
Colucid Pharmaceuticals
January 2006 - January 2012
CMO at
BioVascular Inc
January 2005 - April 2011
Board member at
Protemix
January 2007 - January 2009
CMO at
Avera Pharmaceuticals
January 2002 - January 2004
SVP Clinical at
Elan Pharmaceuticals
January 2001 - January 2002
Senior Vice President, Global Clinical Research at
Dupont Pharmaceuticals
January 1998 - January 2002
Vice President Global Cardiovascular Clinical Research at
Sanofi
January 1996 - January 1998
Director Cardiovascular, CNS and Metabolic Clinical Research at
GSK
January 1988 - January 1996
Clinical Pharmacologist at
GSK
January 1985 - January 1988
Alison Pilgrim
Education
University of Oxford, Bm Bch Dphil
January 1974 - January 1983
Frequently Asked Questions about Alison Pilgrim
What is Alison Pilgrim email address?
Alison Pilgrim's primary email address is *******@humacyte.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Alison Pilgrim work for?
Alison Pilgrim is a Partner at Humacyte, a company specializing in Commercial physical research.
Where Alison Pilgrim graduated from?
Alison Pilgrim holds a degree in Medicine, Neurobiology from University of Oxford.
How can I directly contact Alison Pilgrim?
To contact Alison Pilgrim directly, you can use the email address *******@humacyte.com. Complete contact information is available upon registration with Muraena.
Who is Alison Pilgrim?
Alison Pilgrim is a seasoned professional in the pharmaceutical and biopharmaceutical industry with over three decades of experience. Currently a Partner at Competitive Drug Development SARL, she has held multiple leadership roles including Chief Medical Officer at Humacyte and Colucid Pharmaceuticals. Alison's expertise spans clinical development, drug discovery, and strategic planning, making her a valuable asset in the management of clinical trials and drug development processes. Her academic background includes a DPhil in Medicine and Neurobiology from the University of Oxford, which laid the foundation for her successful career. Known for her strategic insights and innovative approach, she has contributed to the advancement of medical devices and oncology research. Alison's extensive experience in both corporate and consulting environments enhances her adaptability and effectiveness in the fast-paced pharmaceutical landscape.
Alison`s contact details
*******@humacyte.com
********@mac.com
Colleagues
VP Finance, Corporate Controller
Chief Commercial Officer
Chief Quality Officer
Chief People Officer
Adjunct Professor of Anesthesiology & Biomedical Engineering
Chief Medical Officer
Chief Regulatory Officer
Chief Financial Officer and Chief Corporate Development Officer
Vice President, Scientific Affairs
Executive Director Human Resources